MicroA AS is a biotechnology company manufacturing and developing natural, safe and efficacious products from microalgae to address unmet clinical needs. As part of this effort MicroA AS is developing a range of therapeutic and biomaterial applications for its lead compound Prasinoguard®, a high molecular weight, sulfated polysaccharide which is produced using MicroA’s proprietary photobioreactors and processing capability.

The Prasinoguard® pipeline of products includes a candidate biopolymer for the treatment and prevention of respiratory diseases. This work is supported by the Norwegian Research Council under an Innovation Project for the Industrial Sector.